A follicular growth inducing apparatus is suitable for a surgical procedure for inducing follicular growth and is less invasive and less likely to degrade the ovarian functions. The follicular growth inducing apparatus includes an ovarian puncture needle that forms a puncture hole by puncturing an ovary in a traveling direction of ultrasound emitted from a probe in a transvaginal ultrasound device toward the ovary, for inducing growth of follicles, and an optical fiber that guides a laser beam emitted from a laser generator. The ovarian puncture needle includes a needle tube including a basal end, a shaft supported on the basal end, and a needle tip continuous with the shaft. The needle tip punctures the ovary. The optical fiber is installable in the needle tube to have a distal end of the optical fiber adjacent to the needle tip.

There is provided a process for treatment of rhinitis by diode laser ablation of the posterior nasal nerves. The laser diode delivery device with elongated optic tip is inserted through a patient's nostril and has the length, flexibility and a curvature to reach both above and under the patient's middle turbinate for treatment to both posterior nasal nerves. Skin and tissue temperature is raised to approximately 60-65 C. with the process. Optimal treatment wavelength was found to be approximately 380-450 nanometers with blue lasers.

There is provided a process for treatment of rhinitis by diode laser ablation of the posterior nasal nerves. The laser diode delivery device with elongated optic tip is inserted through a patient's nostril and has the length, flexibility and a curvature to reach both above and under the patient's middle turbinate for treatment to both posterior nasal nerves. Skin and tissue temperature is raised to approximately 60-65 C. with the process. Optimal treatment wavelength was found to be approximately 380-450 nanometers with blue lasers.

The present disclosure is directed towards a medical instrument. The medical instrument includes a housing and an end effector assembly operably connected to the housing. The end effector assembly includes first and second jaw members each having a tissue contacting surface, at least one of the first and second jaw members movable between a first, spaced-apart position and a second proximate position, wherein in the second position, the jaw members cooperate to define a cavity configured to receive tissue between the jaw members. The end effector also includes at least one light-emitting element coupled to at least one of the first and second jaw members, the at least one light-emitting element adapted to deliver light energy to tissue grasped between the first and second jaw members to treat the tissue.

The present disclosure is directed towards a medical instrument. The medical instrument includes a housing and an end effector assembly operably connected to the housing. The end effector assembly includes first and second jaw members each having a tissue contacting surface, at least one of the first and second jaw members movable between a first, spaced-apart position and a second proximate position, wherein in the second position, the jaw members cooperate to define a cavity configured to receive tissue between the jaw members. The end effector also includes at least one light-emitting element coupled to at least one of the first and second jaw members, the at least one light-emitting element adapted to deliver light energy to tissue grasped between the first and second jaw members to treat the tissue.

Disclosed is a medical treatment apparatus. The medical treatment apparatus includes a magnetic resonance imaging (MRI) device, configured for imaging of a specific region including a target object and generating a magnetic resonance image; a laser interstitial thermal therapy (LITT) device, including an LITT probe, the LITT probe being positioned close to the target object based on the magnetic resonance image, and being configured to treat the target object by emitting laser; and a temperature measurement element, the temperature measurement element and the LITT probe being integrated as an integrated probe, and the temperature measurement element being configured to obtain a temperature of the target object.

Disclosed is a medical treatment apparatus. The medical treatment apparatus includes a magnetic resonance imaging (MRI) device, configured for imaging of a specific region including a target object and generating a magnetic resonance image; a laser interstitial thermal therapy (LITT) device, including an LITT probe, the LITT probe being positioned close to the target object based on the magnetic resonance image, and being configured to treat the target object by emitting laser; and a temperature measurement element, the temperature measurement element and the LITT probe being integrated as an integrated probe, and the temperature measurement element being configured to obtain a temperature of the target object.

A method for using metastable perfluorocarbon nanodroplets for ultrasonic lysis of blood clots includes administering metastable perfluorocarbon nanodroplets into a blood vessel that includes or that leads to a blood vessel that includes a blood clot, the metastable perfluorocarbon nanodroplets each have a liquid core comprising a perfluorocarbon material that has a boiling point below 25 C. at atmospheric pressure and that remains stable in liquid form at 25 C. at atmospheric pressure. The method further includes applying ultrasound energy to the perfluorocarbon nanodroplets within or surrounding the blood clot, causing the perfluorocarbon nanodroplets to vaporize and convert to bubbles, which cavitate and lyse the blood clot.

The present disclosure is directed towards a medical instrument. The medical instrument includes a housing and an end effector assembly operably connected to the housing. The end effector assembly includes first and second jaw members each having a tissue contacting surface, at least one of the first and second jaw members movable between a first, spaced-apart position and a second proximate position, wherein in the second position, the jaw members cooperate to define a cavity configured to receive tissue between the jaw members. The end effector also includes at least one light-emitting element coupled to at least one of the first and second jaw members, the at least one light-emitting element adapted to deliver light energy to tissue grasped between the first and second jaw members to treat the tissue.

The present disclosure is directed towards a medical instrument. The medical instrument includes a housing and an end effector assembly operably connected to the housing. The end effector assembly includes first and second jaw members each having a tissue contacting surface, at least one of the first and second jaw members movable between a first, spaced-apart position and a second proximate position, wherein in the second position, the jaw members cooperate to define a cavity configured to receive tissue between the jaw members. The end effector also includes at least one light-emitting element coupled to at least one of the first and second jaw members, the at least one light-emitting element adapted to deliver light energy to tissue grasped between the first and second jaw members to treat the tissue.